Search research articles
Contact Us
Filters
Showing results (211-220 of 218) with videos related to
Page
of 22
Sort By:
You have reached the last page of results.
This site can display upto 218 results.
The Tohoku Journal of Experimental Medicine
|
April 7, 2011
CXC chemokine ligand 16 as a prognostic marker in patients with intermediate coronary artery lesions: a 2-year follow-up study
Kai Tan, Shuzheng Lu, Yundai Chen, et al.
The American Journal of Cardiology
|
September 29, 2025
Causes of In-Hospital Death in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention in Beijing Area
Jing Li, Yinghua Zhang, Yixin Ma, et al.
BMJ Open
|
December 10, 2023
Rationale and design of a comparison of angiography-derived fractional flow reserve-guided and intravascular ultrasound-guided intervention strategy for clinical outcomes in patients with coronary artery disease: a randomised controlled trial (FLAVOUR II)
Jinlong Zhang, Xinyang Hu, Jun Jiang, et al.
Journal of the American College of Cardiology
|
June 10, 2026
Angiographic Quantitative Flow Ratio-Guided Coronary Intervention: 5-Year Follow-Up From the FAVOR III China Randomized Trial
Han Zhang, Changdong Guan, Zening Jin, et al.
Journal of the American College of Cardiology
|
November 24, 2022
2-Year Outcomes of Angiographic Quantitative Flow Ratio-Guided Coronary Interventions
Lei Song, Bo Xu, Shengxian Tu, et al.
Lancet (London, England)
|
April 2, 2025
Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease (FLAVOUR II): a multicentre, randomised, non-inferiority trial
Xinyang Hu, Jinlong Zhang, Seokhun Yang, et al.
Circulation. Cardiovascular Interventions
|
May 19, 2026
Angiography-Derived FFR versus IVUS to Guide PCI According to Angiographic Lesion Characteristics
Seokhun Yang, Xinyang Hu, Jinlong Zhang, et al.
Lancet (London, England)
|
November 7, 2021
Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial
Bo Xu, Shengxian Tu, Lei Song, et al.
Page
of 22
Search research articles
Search
Showing results (211-220 of 218) with videos related to
Sort By:
Page
of 22
You have reached the last page of results.
This site can display upto 218 results.
The Tohoku Journal of Experimental Medicine
|
April 7, 2011
CXC chemokine ligand 16 as a prognostic marker in patients with intermediate coronary artery lesions: a 2-year follow-up study
Kai Tan, Shuzheng Lu, Yundai Chen, et al.
The American Journal of Cardiology
|
September 29, 2025
Causes of In-Hospital Death in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention in Beijing Area
Jing Li, Yinghua Zhang, Yixin Ma, et al.
BMJ Open
|
December 10, 2023
Rationale and design of a comparison of angiography-derived fractional flow reserve-guided and intravascular ultrasound-guided intervention strategy for clinical outcomes in patients with coronary artery disease: a randomised controlled trial (FLAVOUR II)
Jinlong Zhang, Xinyang Hu, Jun Jiang, et al.
Journal of the American College of Cardiology
|
June 10, 2026
Angiographic Quantitative Flow Ratio-Guided Coronary Intervention: 5-Year Follow-Up From the FAVOR III China Randomized Trial
Han Zhang, Changdong Guan, Zening Jin, et al.
Journal of the American College of Cardiology
|
November 24, 2022
2-Year Outcomes of Angiographic Quantitative Flow Ratio-Guided Coronary Interventions
Lei Song, Bo Xu, Shengxian Tu, et al.
Lancet (London, England)
|
April 2, 2025
Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease (FLAVOUR II): a multicentre, randomised, non-inferiority trial
Xinyang Hu, Jinlong Zhang, Seokhun Yang, et al.
Circulation. Cardiovascular Interventions
|
May 19, 2026
Angiography-Derived FFR versus IVUS to Guide PCI According to Angiographic Lesion Characteristics
Seokhun Yang, Xinyang Hu, Jinlong Zhang, et al.
Lancet (London, England)
|
November 7, 2021
Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial
Bo Xu, Shengxian Tu, Lei Song, et al.
Page
of 22